Skip to content

Opening book details…

About this Medicine article

A single‐ and multiple‐ascending dose study to evaluate the safety and pharmacokinetics of oral PU‐AD, an epichaperome inhibitor to treat Alzheimer’s disease: Human/Trial design by Michael Silverman; Barbara Wallner; Cassandra Key; Susan M. Duggan; Laurie Reynolds is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Michael Silverman; Barbara Wallner; Cassandra Key; Susan M. Duggan; Laurie Reynolds
Publisher
Elsevier Science; Elsevier ; Elsevier BV; Wiley; Research Square (ISSN 1552-5260)
Published
2020
Language
EN
Field
Medicine (Health Sciences)

More by Michael Silverman; Barbara Wallner; Cassandra Key; Susan M. Duggan; Laurie Reynolds

Browse all works by Michael Silverman; Barbara Wallner; Cassandra Key; Susan M. Duggan; Laurie Reynolds